Business Wire

OH-PROCTER-&-GAMBLE

26.8.2021 19:17:05 CEST | Business Wire | Press release

Share
P&G Studios and Harder Than You Think Foster Game Changing Conversations in New Podcast Series “Equal Too: Achieving Disability Equality”

Today, P&G Studios and the team at Harder Than You Think launch a new podcast series, “Equal Too: Achieving Disability Equality,” to shine a light on the biggest challenges faced by the disabled community and start a conversation about what is needed to drive equality. The podcast, hosted by UK television presenter and disability advocate Sophie Morgan, will focus on challenging perceptions, celebrating successes, and exploring how to transform the world for those who do and do not have a disability. Sophie will speak with some of the most informed and most famous professionals, influencers, and activists about key themes of disability and inclusion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210826005660/en/

“Equal Too” is a special six-part series featured on the podcast Seneca’s Conversations on Power and Purpose and is brought to you by the Seneca Women Podcast Network and iHeart Radio. The series will run through August and September and will explore thought-provoking topics, like:

  • The legacy of the Paralympic Movement and the lasting impact hosting the Paralympic Games has had on host cities and beyond
  • How legislation for disabled people is changing and what more needs to be done
  • The path of employment for disabled people 70 years after Sir Ludwig Guttmann began using sport to create space for disabled people in society

For “Equal Too,” the talented team behind the award-winning Netflix documentary Rising Phoenix have brought together an abundance of voices who are policymakers, activists, athletes, and allies from across the globe, including:

  • Jameela Jamil, actor and host recognized as an advocate for disability rights, LGBTQ+ rights, body neutrality, and her work as founder of the I Weigh Community
  • RJ Mitte, an American actor, advocate, and philanthropist who has been a global champion in speaking of his experiences with Cerebral Palsy in hopes of removing the stigma associated with disabilities
  • Tatyana McFadden, a Russian-American athlete who holds 17 Paralympic medals, whose efforts to advocate for disability equality led to the passage of several pieces of legislation to ensure students with disabilities have equal access to compete in athletics
  • Andrew Parsons, a Brazilian sports administrator, and the president of the International Paralympic Committee (IPC). The IPC and the International Disability Alliance recently spearheaded the launch of the #WeThe15 campaign, a global movement to represent the 1.2 billion people with disabilities in the world

“With ‘Equal Too’ bringing together so many powerful and influential voices, it will help us to work out where the Rising Phoenix story needs to go next,” said Greg Nugent, co-founder of Harder Than You Think and creator of Rising Phoenix . “The threads to the conversation are extraordinary and important and the need for the story to be told is more vital than ever.”

As the world turns its focus to the incredible athletes competing in the Paralympic Games and inspired by the recent launch of the IPC’s #WeThe15 initiative, the biggest disability equality movement of its kind, P&G is committing a $100,000 donation to the Agitos Foundation. This will help fuel the work of the IPC to change how young people perceive those with a disability.

“We believe that greater visibility is a critical step to changing perceptions on the journey to disability equality,” said Phil Duncan, P&G’s Chief Design Officer and Olympic Games Executive. “We all have more to learn, which is why it’s important for us to spotlight the hugely important conversations in ‘Equal Too.’ We are also proud to make a monetary donation to the Agitos Foundation, which is doing incredibly impactful work in raising long lasting awareness for the next generation.”

As meaningful conversations about inclusivity can only be made possible when equal voices are represented, “Equal Too” is made possible by a team – from producers to guests and contributors – comprised of more than 60% of people who identify as disabled. At the helm of the project are two influential women: host and executive producer Sophie Morgan and executive producer and story consultant Sinéad Burke. Sophie, who was paralyzed in a car crash when she was 18, is an award-winning broadcaster who has presented for Channel 4 at every Paralympic Games since the Paralympic Games London 2012 and is one of the first and only female, disabled television hosts in the world. Sinéad, the founder of accessibility consultancy, Tilting the Lens, is a little person who campaigns to raise the baseline standards of accessibility to build a world that is designed with disabled people, for the inclusion of all.

All episodes of the podcast will be released with downloadable transcripts available shortly thereafter. Additionally, they will be accompanied with captioned videos featuring a deaf British Sign Language signer, Rinkoo Barpaga. You can download and listen to “Equal Too,” part of Seneca's Conversations, on the iHeartradio App, Apple Podcasts, or whichever podcast player you use.

About Procter & Gamble

P&G serves consumers around the world with one of the strongest portfolios of trusted, quality, leadership brands, including Always®, Ambi Pur®, Ariel®, Bounty®, Charmin®, Crest®, Dawn®, Downy®, Fairy®, Febreze®, Gain®, Gillette®, Head & Shoulders®, Lenor®, Olay®, Oral-B®, Pampers®, Pantene®, SK-II®, Tide®, Vicks®, and Whisper®. The P&G community includes operations in approximately 70 countries worldwide. Please visit http://www.pg.com for the latest news and information about P&G and its brands. For other P&G news, visit us at www.pg.com/news .

About P&G Studios

P&G Studios develops and produces stories to help create positive change in society, often shining the light on under-represented voices and acts of good. Like-minded, mission-based creative innovators and innovative NGO organizations partner with P&G Studios to meet the growing demand for authentic stories that uplift and inspire. Recent programs include The Queen Collective and 8:46 films, the National Geographic ACTIVATE Series, The Tent Mender documentary series, TIME 100 Most Influential People of the Year and TIME Person of the Year one-hour specials, Coded short documentary, and the launch of the Seneca Women’s Podcast Network.

About Harder Than You Think

Harder Than You Think is an independent production company whose purpose is to help change the way we think using the power of the story. Harder Than You Think was created and co-founded by Greg Nugent and Godric Smith, formerly Directors of the London 2012 Olympics and Paralympics. Greg and Godric’s work includes the creation of the Heads Together Campaign for Their Royal Highnesses using film, which went on to transform the views of the nation on mental health, and the creation of The Earthshot Prize, which has become the most important award on the plant for action on the environment.

Rising Phoenix is a ten-year mission by Harder Than You Think that aims to change the way the world thinks about human potential. The project was born out of the success of Harder Than You Think's debut film ‘Rising Phoenix,’ a landmark and double Emmy winning feature documentary about the history of the Paralympic Movement released in 2020 on Netflix, and via further films and audio projects in development to tell the story of the next decade.

About Seneca Women

Co-founded by Ambassador Melanne Verveer, the first U.S. Ambassador for Global Women’s Issues, and Kim Azzarelli, a corporate, philanthropic and legal advisor, who together co-authored the best-selling book Fast Forward: How Women Can Achieve Power and Purpose, and joined by Sharon Bowen, former Commissioner of the U.S. Commodity Futures Trading Commission, Seneca Women has sought to accelerate women’s progress through signature thought leadership events at Davos, the Metropolitan Museum of Art and the New York Stock Exchange, as well as through the Seneca Women app, a weekly newsletter, and significant partnerships with the public and private sectors. The Seneca Women Podcast Network provides a platform for the voices of women as well as inspiring, purpose-driven and inclusive content.

About iHeartMedia

iHeartMedia (NASDAQ: IHRT) is the number one audio company in the United States, reaching nine out of 10 Americans every month – and with its quarter of a billion monthly listeners, has a greater reach than any other media company in the U.S. The company’s leadership position in audio extends across multiple platforms, including more than 850 live broadcast stations in over 160 markets nationwide; through its iHeartRadio digital service available across more than 250 platforms and 2,000 devices; through its influencers; social; branded iconic live music events; other digital products and newsletters; and podcasts as the #1 commercial podcast publisher. iHeartMedia also leads the audio industry in analytics, targeting and attribution for its marketing partners with its SmartAudio product, using data from its massive consumer base.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Consortium Led by Axelspace Selected for Japan’s Space Strategy Fund Project “Technology to Enhance Capability of Next Generation Earth Observation Satellites”30.3.2026 01:35:00 CEST | Press release

~ Creating Climate Solutions and New Market Opportunities through Source-Specific CO2 Emission and Uptake Monitoring via Satellite Constellation and Aircraft ~ Axelspace Corporation, Meisei Electric Co., Ltd., ANA HOLDINGS INC., and JIJ Inc. are pleased to announce that their jointly proposed technology development project has been selected for Japan Aerospace Exploration Agency (JAXA)’s Space Strategy Fund under the theme “Technology to Enhance Capability of Next Generation Earth Observation Satellites.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260323044518/en/ Conceptual Diagram of the project. Under this Space Strategy Fund initiative, spectrometers will be newly developed and demonstrated in orbit. In the future, the project envisions the establishment of a satellite constellation capable of observations at different times of the day. Project Summary (Planned) Technology Development Theme: Technology to Enhance Cap

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting28.3.2026 20:00:00 CET | Press release

Phase 3 data from the STOP-HS program demonstrate povorcitinib’s substantial and durable clinical efficacy through Week 54 in patients with moderate to severe hidradenitis suppurativa (HS). Through Week 54, clinically meaningful and durable responses were observed across all groups in both STOP-HS1 and STOP-HS2, with up to 71.4% of patients achieving HiSCR50. Improvements in clinical responses across high stringent thresholds were observed, with up to 57% of participants achieving HiSCR75 and up to 29% of participants achieving HiSCR100. Povorcitinib treatment led to consistent reductions across key inflammatory lesion types, with full resolution (ANdT=0) achieved in up to 20% of patients. Additionally, clinically meaningful improvements in quality-of-life measures, including skin pain and fatigue, were observed at Week 54. The overall safety profile of povorcitinib through 54 weeks is consistent with previously reported data, and both doses were well tolerated. Incyte (Nasdaq:INCY) to

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care28.3.2026 20:00:00 CET | Press release

About 70% of patients treated with zasocitinib achieved clear or almost clear skin (sPGA 0/1) at week 16 in Phase 3 plaque psoriasis studies A significantly greater PASI 75 response rate versus placebo was observed as early as week 4 Safety profile consistent with Phase 2b studies with no new safety signals identified Takeda(TSE:4502/NYSE:TAK)today announced new data from the two pivotal Phase 3studies of zasocitinib (TAK-279), a next-generation, highly selective oral tyrosine kinase 2 (TYK2) inhibitor, in adults with moderate-to-severe plaque psoriasis (PsO).1 Presented as a late-breaking abstract at the 2026 American Academy of Dermatology (AAD) Annual Meeting, these data show that convenient once-daily oral zasocitinib demonstrated rapid and durable skin clearance with a safety profile consistent with Phase 2b studies.1,2 “Our goal in psoriasis treatment is clear or almost clear skin, and previously this has been achieved primarily with injectable therapies,” said Melinda Gooderham,

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis28.3.2026 16:00:00 CET | Press release

Pharmacokinetics, safety and efficacy clinical study data show that nemolizumab achieved clinically meaningful reductions in skin lesions and itch through Week 16, which were sustained up to a year in children aged 2 to 11 with moderate-to-severe atopic dermatitis1 These findings reinforce the previously established safety and efficacy of nemolizumab in adults and adolescents with moderate-to-severe atopic dermatitis, for which it is approved by multiple global regulatory authorities2,3 Up to 25% of children are affected by atopic dermatitis, and currently there are limited approved treatment options for children living with moderate-to-severe atopic dermatitis4,5 Galderma (SIX: GALD) today announced new phase II data showing that nemolizumab was well tolerated and effective in children (aged 2 to 11 years) with moderate-to-severe atopic dermatitis, with a clinically meaningful and sustained reduction in skin lesions and itch for up to a year.1 Results will be presented in a late-break

Angelalign Technology (6699.HK)Releases 2025 Results: Passion for Clinical Excellence Drives Worldwide Growth27.3.2026 20:56:00 CET | Press release

Angelalign Technology Inc. (6699.HK) (“Angel” or the “Company”) released its financial results for fiscal year 2025. During the reporting period, the Company continued to do well in both the global and China markets. Total case volume was 532,400, which increased 48.1%, revenue was USD 370.3 million, which increased 37.8%, and adjusted net profit was USD 43.8 million, which increased 63.0%. The results were driven by Angel’s passion for clinical excellence and its open and inclusive culture that empowers talented people to work together to meet customer needs, the Company said. Fox Hu, CEO of Angel, stated: “The clear aligner industry is complex and multidisciplinary. It requires top-tier technical and operational talent along with seamless collaboration among professionals from diverse geographies. Angel’s open and inclusive culture attracts professionals who share a passion for clinical excellence and a dedication to bringing outstanding products and services to customers. This melti

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye